Cargando…

Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients

BACKGROUND: Recent observations suggest that immune-mediated tissue destruction is dependent upon coordinate activation of immune genes expressed by cells of the innate and adaptive immune systems. METHODS: Here, we performed a retrospective pilot study to investigate whether the coordinate expressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ascierto, Maria Libera, Idowu, Michael O, Zhao, Yingdong, Khalak, Hanif, Payne, Kyle K, Wang, Xiang-Yang, Dumur, Catherine I, Bedognetti, Davide, Tomei, Sara, Ascierto, Paolo A, Shanker, Anil, Bear, Harry D, Wang, Ena, Marincola, Francesco M, De Maria, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694475/ https://www.ncbi.nlm.nih.gov/pubmed/23758773 http://dx.doi.org/10.1186/1479-5876-11-145

Ejemplares similares

Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure
por: Kmieciak, Maciej, et al.
Publicado: (2011)

Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus
por: Ascierto, Maria Libera, et al.
Publicado: (2015)

Genomic scale analysis of NK cells impact on response to IFN-α
por: Ascierto, Maria L, et al.
Publicado: (2013)

The stable traits of melanoma genetics: an alternate approach to target discovery
por: Spivey, Tara L, et al.
Publicado: (2012)

Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population
por: Tomei, Sara, et al.
Publicado: (2012)

NGS technology applied to melanoma cell lines
por: De Giorgi, Valeria, et al.
Publicado: (2013)

Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCV
por: Marras, Francesco, et al.
Publicado: (2014)

IRF5 gene polymorphisms in melanoma
por: Uccellini, Lorenzo, et al.
Publicado: (2012)

Distinct signatures of the immune responses in low risk versus high risk neuroblastoma
por: Gowda, Madhu, et al.
Publicado: (2011)

The immune‐related role of BRAF in melanoma
por: Tomei, Sara, et al.
Publicado: (2014)

The immune-related role of BRAF in melanoma
por: Tomei, Sara, et al.
Publicado: (2015)

IRF-1 responsiveness to immune cytokines predicts different cancer phenotypes
por: Murtas, Daniela, et al.
Publicado: (2013)

Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity
por: Mendoza-Valderrey, Alberto, et al.
Publicado: (2022)

Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis
por: Spivey, Tara L, et al.
Publicado: (2011)

Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy
por: Ascierto, Maria Libera, et al.
Publicado: (2015)

An immunologic portrait of cancer
por: Ascierto, Maria Libera, et al.
Publicado: (2011)

Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68
por: Ascierto, Maria Libera, et al.
Publicado: (2011)

Genetic inference of immune responsiveness of melanoma cancer patients to TIL therapy
por: Sommariva, Michele, et al.
Publicado: (2013)

Combination therapy: the next opportunity and challenge of medicine
por: Ascierto, Paolo A, et al.
Publicado: (2011)

What have we learned from cancer immunotherapy in the last 3 years?
por: Ascierto, Paolo A, et al.
Publicado: (2014)

2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond
por: Ascierto, Paolo A., et al.
Publicado: (2015)

Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
por: Bedognetti, Davide, et al.
Publicado: (2014)

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
por: Ascierto, Paolo A, et al.
Publicado: (2011)

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, December 5(th) 2015
por: Ascierto, Paolo A., et al.
Publicado: (2016)

Reflections upon human cancer immune responsiveness to T cell-based therapy
por: Wang, Ena, et al.
Publicado: (2012)

What’s new in melanoma? Combination!
por: Ascierto, Paolo A, et al.
Publicado: (2015)

Main roads to melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2009)

‘Emergency exit' of bone-marrow-resident CD34(+)DNAM-1(bright)CXCR4(+)-committed lymphoid precursors during chronic infection and inflammation
por: Bozzano, Federica, et al.
Publicado: (2015)

Intradermal influenza vaccination in complete remission cancer patients: molecular insights
por: Bedognetti, Davide, et al.
Publicado: (2013)

IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes
por: Murtas, D, et al.
Publicado: (2013)

Melanoma: From Research to Treatment
por: Ascierto, Paolo A., et al.
Publicado: (2011)

No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study
por: Ascierto, Paolo A., et al.
Publicado: (2020)

Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma
por: Johnson, Jennifer, et al.
Publicado: (2015)

CD8(+) T Lymphocyte and NK Cell Network: Circuitry in the Cytotoxic Domain of Immunity
por: Uzhachenko, Roman V., et al.
Publicado: (2019)

Lean oncology: a new model for oncologists
por: Montesarchio, Vincenzo, et al.
Publicado: (2012)

A strategy for detection of known and unknown SNP using a minimum number of oligonucleotides applicable in the clinical settings
por: Wang, Ena, et al.
Publicado: (2003)

CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
por: Bedognetti, D, et al.
Publicado: (2013)

Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection
por: Weibel, Stephanie, et al.
Publicado: (2011)

Evaluation of normalization methods for two-channel microRNA microarrays
por: Zhao, Yingdong, et al.
Publicado: (2010)

Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients
por: Tallerico, Rossana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6alqo2je73ui60rmtiimo4mm5s